Skip to content

Lumbar sympathetic anhydrous ethanol injection combined with thoracoscopic T4-5 sympathotomy in the treatment of primary hand-foot hyperhidrosis: the effect of surgical sequence on compensatory hyperhidrosis

Lumbar sympathetic anhydrous ethanol injection combined with thoracoscopic T4-5 sympathotomy in the treatment of primary hand-foot hyperhidrosis: the effect of surgical sequence on compensatory hyperhidrosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059847
Enrollment
Unknown
Registered
2022-05-12
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary hyperhidrosis

Interventions

Experimental group:Lumbar sympathetic nerve block was performed first, followed by thoracoscopic sympathectomy
Control group:Thoracoscopic sympathectomy was performed first, followed by lumbar sympathectomy

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients with primary hand-foot hyperhidrosis with HDSS >= 2; 2. BMI <=28; 3. Age 18-50 years old; 4. Patients and their families have a strong desire for surgery and voluntarily join the study.

Exclusion criteria

Exclusion criteria: 1. Infection, endocrine disorders, neuroendocrine tumors, malignant tumors, nervous system diseases, hyperthyroidism, tuberculosis and other secondary hand and foot hyperhidrosis; 2. Severe bradycardia (HR<55 beats/min), combined with severe cardiopulmonary and other systemic diseases; 3. Combined with spinal deformity, abnormal blood coagulation, etc. who are not suitable for invasive puncture and surgery.

Design outcomes

Primary

MeasureTime frame
Incidence of compensatory hyperhidrosis;

Secondary

MeasureTime frame
Severity of compensatory hyperhidrosis;Quality of life before and 3 months after surgery;Preoperative and postoperative pain assessment;Adverse reactions from the beginning of treatment to 3 months after completion;Overall patient satisfaction;Security detection;

Countries

China

Contacts

Public ContactLing Ye

West China Hospital, Sichuan University

zerodq_hx@163.com+86 18980601894

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026